Download Are SC Patients Receiving Standards of Care for Breast and Colon

SOUTH CAROLINA
South Carolina Central Cancer Registry
Are SC Patients Receiving Standards of Care for
Breast and Colon Cancer: Using Cancer Registry
Treatment Data in the State Cancer Control Plan
NATIONAL PROGRAM OF CANCER REGISTRIES
SUCCESS STORY
Public Health Problem: SC has known health
disparities, evidenced by differences in cancer
incidence and mortality rates by county and by
race. There has never been a statewide evaluation performed on whether nationally accepted
treatment standards of care are being followed
for SC cancer patients. The extent to which
treatment standards are followed could impact
patient outcomes, specifically cancer mortality/
survival. Examining treatment trends will help
target issues related to cancer disparities in SC.
months (120 days) of diagnosis for patients
under the age of 80 with AJCC Stage III
(lymph node positive) colon cancer.
5. Colon Cancer Measure: At least 12 regional
lymph nodes are removed and pathologically examined for resected colon cancer.
Collaboration: The major collaborator for this
assessment is the SC Cancer Alliance (SCCA),
the statewide coalition for cancer prevention
and control. The SCCA is responsible for revising the SC Cancer Control Plan. Inclusion of
additional data-driven objectives was the focus
for the latest revision of the Plan in 2010-11.
The SCCCR Director, serving on the
SC State Cancer Control Revision Committee, recommended that objectives be added
into the plan based on these clinical checks
in order to evaluate cancer treatment in the
state. The recommendation was endorsed by
the ACoS CoC State Cancer Liaison Physician,
and accepted by the Committee. Objectives were then developed based on the
clinical checks and included in the 2011 Revision of the State Cancer Control Plan.
Use of Surveillance Data: Five quality of care
measures were developed and agreed upon by
CoC, ASCO, and NCCN regarding first course of
treatment for hospitals in recent years. (http://
www.facs.org/cancer/qualitymeasures.html)
Clinical checks based on these measures were then developed for use in central
cancer registries and presented at the NPCR
Program Directors Meeting in 2010.
They include:
1. Breast Cancer Measure: Radiation therapy
is administered within 1 year (365 days) of
diagnosis for women under age 70 receiving
breast conserving surgery for breast cancer.
2. Breast Cancer Measure: Combination chemo- Public Health Outcome: The SCCCR protherapy is considered or administered within duced baseline measures using 2006-2010
4 months (120 days) of diagnosis for women data for breast and colon cancer, years for
under 70 with AJCC T1cN0M0, or Stage II or which complete treatment was reported.
III hormone receptor negative breast cancer.
The baseline data results are being
3. Breast Cancer Measure: Tamoxifen or third
presented to SCCA workgroup leaders for
generation aromatase inhibitor is conbreast and colon cancer in 2013 to begin
sidered or administered within 1 year
to address these objectives. Trends will be
(365 days) of diagnosis for women with
followed in upcoming years to measure
AJCC T1cN0M0, or Stage II or III horimprovement in implementation of these
mone receptor positive breast cancer.
treatment standards and educational inter4. Colon Cancer Measure: Adjuvant chemother- vention will be implemented as needed.
apy is considered or administered within 4